secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcus Biosciences, Inc. (RCUS)
CIK:        0001724521
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001193125-25-262589
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcus Biosciences closes public offering of 15.76M shares, net proceeds ~$269.7M
--------------------------------------------------------------------------------

- Sold 15,755,000 shares at $18.25 per share including full exercise of underwriters' option.
- Net proceeds of approximately $269.7 million after discounts and estimated expenses.
- Underwriters led by Leerink Partners LLC and Goldman Sachs & Co. LLC.
- Offering closed on November 3, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1724521/000119312525262589/0001193125-25-262589-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1724521/000119312525262589/d912891d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-262589

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer